close
Choose Your Site
Global
Social Media
loading
loading
Mirogabalin besylate is a novel oral ligand for the α2δ subunit of voltage-gated calcium channels. It is a potent and selective drug developed for the treatment of neuropathic pain, particularly diabetic peripheral neuropathy (DPN) and postherpetic neuralgia (PHN). Compared to pregabalin, Mirogabalin demonstrates improved pharmacokinetics, higher receptor selectivity, and fewer side effects.
Our Mirogabalin Besylate is manufactured under GMP conditions, suitable for both R&D and formulation production.
Applications:
Diabetic Peripheral Neuropathy treatment
Postherpetic Neuralgia management
Neuropathic pain relief research
Clinical trial formulation
Packaging:
Available in 10g, 100g, 1kg foil bags or customized upon request
Storage Conditions:
Store in a tightly sealed container, in a dry and cool environment. Recommended temperature: 2–8°C
